The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · cited 1×
“As for the precursor, it could be the major proglucagon fragment, which has a molecular mass compatible with that of the observed band [1, 8, 28].”
BackgroundThe Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2513 · Cited by 922
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients
Toft-Nielsen, M.-B., Damholt, M. B., Madsbad, S., Hilsted, L. M., Hughes, T. E., Michelsen, B. K., & Holst, J. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7750 · Cited by 869
Endoplasmic reticulum stress, obesity and diabetes
Cnop, M., Foufelle, F., & Velloso, L. A. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.07.010 · Cited by 682
Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
Nauck, M. A., Vardarli, I., Deacon, C. F., Holst, J. J., & Meier, J. J. (2011) · Diabetologia · doi:10.1007/s00125-010-1896-4 · Cited by 465 · cited 1×
“Although type 2 diabetic patients may release less GLP-1, which could contribute to decreased incretin effects in this patient group [1, 41–43], it cannot be ruled out that the reduced concentrations of active GLP-1 in such patients might be partly due to increased DPP-4 activity.”
BackgroundUnique Arrangement of α- and β-Cells in Human Islets of Langerhans
Bosco, D., Armanet, M., Morel, P., Niclauss, N., Sgroi, A., Muller, Y. D., Giovannoni, L., Parnaud, G., & Berney, T. (2010) · Diabetes · doi:10.2337/db09-1177 · Cited by 450
Incretins, insulin secretion and Type 2 diabetes mellitus
Vilsbøll, T., & Holst, J. J. (2004) · Diabetologia · doi:10.1007/s00125-004-1342-6 · Cited by 444
Diamant, M., Van Gaal, L., Stranks, S., Northrup, J., Cao, D., Taylor, K., & Trautmann, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60406-0 · Cited by 434 · cited 4×
“GLP-1-like immunoreactivity was detected by a polyclonal and a monoclonal anti-GLP-1 antibody reacting, respectively, with the mid to C terminal region of GLP-1 [1–19] and the amidated C-terminus of the peptide (see the Methods).”
BackgroundInfluentialThe endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients
Marchetti, P., Bugliani, M., Lupi, R., Marselli, L., Masini, M., Boggi, U., Filipponi, F., Weir, G. C., Eizirik, D. L., & Cnop, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0816-8 · Cited by 413 · cited 2×
“Islet isolation and culture Islets were prepared by enzymatic digestion and gradient separation [22, 23], and suspended in M199 culture medium (Sigma Chemicals, St Louis, MO, USA) supplemented as detailed elsewhere [22, 23].”
MethodSelf-citationStructural and Functional Abnormalities in the Islets Isolated From Type 2 Diabetic Subjects
Deng, S., Vatamaniuk, M., Huang, X., Doliba, N., Lian, M.-M., Frank, A., Velidedeoglu, E., Desai, N. M., Koeberlein, B., Wolf, B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.3.624 · Cited by 349
Alpha cell function in health and disease: influence of glucagon-like peptide-1
Dunning, B. E., Foley, J. E., & Ahrén, B. (2005) · Diabetologia · doi:10.1007/s00125-005-1878-0 · Cited by 271
Glucagon-like peptide analogues for type 2 diabetes mellitus
Shyangdan, D. S., Royle, P., Clar, C., Sharma, P., Waugh, N., & Snaith, A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006423.pub2 · Cited by 246 · cited 2×
“GLP-1-like immunoreactivity was detected by a polyclonal and a monoclonal anti-GLP-1 antibody reacting, respectively, with the mid to C terminal region of GLP-1 [1–19] and the amidated C-terminus of the peptide (see the Methods).”
BackgroundProliferation of sorted human and rat beta cells
Parnaud, G., Bosco, D., Berney, T., Pattou, F., Kerr-Conte, J., Donath, M. Y., Bruun, C., Mandrup-Poulsen, T., Billestrup, N., & Halban, P. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0855-1 · Cited by 232
Igoillo-Esteve, M., Marselli, L., Cunha, D. A., Ladrière, L., Ortis, F., Grieco, F. A., Dotta, F., Weir, G. C., Marchetti, P., Eizirik, D. L., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1707-y · Cited by 227
Self-citationHyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus
Mannucci, E., Pala, L., Ciani, S., Bardini, G., Pezzatini, A., Sposato, I., Cremasco, F., Ognibene, A., & Rotella, C. M. (2005) · Diabetologia · doi:10.1007/s00125-005-1749-8 · Cited by 206 · cited 1×
“Increased plasma DPP-4 activity in type 2 diabetic patients has been reported [44], and chronic hyperglycaemia induced higher DPP-4 activity, with reductions of circulating active GLP-1 [45].”
BackgroundPancreatic alpha cell mass in European subjects with type 2 diabetes
Henquin, J. C., & Rahier, J. (2011) · Diabetologia · doi:10.1007/s00125-011-2118-4 · Cited by 185
Proglucagon processing in porcine and human pancreas.
Holst, J. J., Bersani, M., Johnsen, A. H., Kofod, H., Hartmann, B., & Orskov, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32241-x · Cited by 181
Ryskjær, J., Deacon, C. F., Carr, R. D., Krarup, T., Madsbad, S., Holst, J., & Vilsbøll, T. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02221 · Cited by 181
Whalley, N. M., Pritchard, L. E., Smith, D. M., & White, A. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0094 · Cited by 178
Regulation of glucagon secretion by glucose: paracrine, intrinsic or both?
Walker, J. N., Ramracheya, R., Zhang, Q., Johnson, P. R. V., Braun, M., & Rorsman, P. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01450.x · Cited by 176
Mojsov, S., Kopczynski, M. G., & Habener, J. F. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39030-1 · Cited by 159
Fujita, Y., Wideman, R. D., Asadi, A., Yang, G. K., Baker, R. K., Webber, T. D., Zhang, T., Wang, R., Ao, Z., Warnock, G. L., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.049 · Cited by 153
Identification and Purification of Functional Human β-cells by a New Specific Zinc-fluorescent Probe
Lukowiak, B., Vandewalle, B., Riachy, R., Kerr-Conte, J. A., Gmyr, V., Belaich, S., Lefèbvre, J., & Pattou, F. N. (2001) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540104900412 · Cited by 152
Kilimnik, G., Kim, A., Steiner, D. F., Friedman, T. C., & Hara, M. (2010) · Islets · doi:10.4161/isl.2.3.11396 · Cited by 136
Varndell, I. M., Bishop, A. E., Sikri, K. L., UTTENTHAL, L. O., Bloom, S. R., & Polak, J. M. (1985) · Journal of Histochemistry & Cytochemistry · doi:10.1177/33.10.3900195 · Cited by 131
Ontogeny of Regeneration of β-Cells in the Neonatal Rat after Treatment with Streptozotocin
Thyssen, S. M., Arany, E. J., & Hill, D. J. (2006) · Endocrinology · doi:10.1210/en.2005-0396 · Cited by 115
Wideman, R. D., Yu, I. L. Y., Webber, T. D., Verchere, C. B., Johnson, J. D., Cheung, A. T., & Kieffer, T. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600655103 · Cited by 109
Wilson, M. E., Kalamaras, J., & German, M. S. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00118-1 · Cited by 100
Liu, Z., Stanojevic, V., Avadhani, S., Yano, T., & Habener, J. F. (2011) · Diabetologia · doi:10.1007/s00125-011-2181-x · Cited by 95
Hansen, A. M. K., Bödvarsdóttir, T., Nordestgaard, D. N. E., Heller, R. S., Gotfredsen, C. F., Maedler, K., Fels, J. J., Holst, J. J., & Karlsen, A. E. (2011) · Diabetologia · doi:10.1007/s00125-011-2080-1 · Cited by 89
Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide
Heller, R. S., & Aponte, G. W. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.269.6.g852 · Cited by 76
Wideman, R. D., Covey, S. D., Webb, G. C., Drucker, D. J., & Kieffer, T. J. (2007) · Diabetes · doi:10.2337/db07-0563 · Cited by 74
Goals of Treatment for Type 2 Diabetes
Marchetti, P., Lupi, R., Guerra, S. D., Bugliani, M., D’Aleo, V., Occhipinti, M., Boggi, U., Marselli, L., & Masini, M. (2009) · Diabetes Care · doi:10.2337/dc09-s306 · Cited by 70
Self-citationMasur, K., Tibaduiza, E. C., Chen, C., Ligon, B., & Beinborn, M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0350 · Cited by 62
Kirkpatrick, C. L., Marchetti, P., Purrello, F., Piro, S., Bugliani, M., Bosco, D., de Koning, E. J. P., Engelse, M. A., Kerr-Conte, J. A., Pattou, F. N., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011053 · Cited by 58
Self-citationGlucagon and Glucagon-Like Peptides 1 and 2
Holst, J. J. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2009_35 · Cited by 56
GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors
Åhrén, B. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0056-9 · Cited by 54
Molecular Forms of Glucagon-Like Peptide-1 in Human Pancreas and Glucagonomas
UTTENTHEL, L. O., Ghiglione, M., George, S. K., Bishop, A. E., Polak, J. M., & Bloom, S. R. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-3-472 · Cited by 52
(Pro)Insulin processing: A historical perspective
Davidson, H. W. (2004) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:40:3:143 · Cited by 48
Meier, J. J., Ueberberg, S., Korbas, S., & Schneider, S. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00315.2010 · Cited by 36
Mathieu, C., & Bollaerts, K. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01437.x · Cited by 33
Portela‐Gomes, G. M., Grimelius, L., & Stridsberg, M. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.09.019 · Cited by 32
Kreymann, B., Ghatei, M. A., Domin, J., Kanse, S. M., & Bloom, S. R. (1991) · Endocrinology · doi:10.1210/endo-129-2-1001 · Cited by 26
Marinis, Y. Z. D., Zhang, E., Amisten, S., Taneera, J., Renström, E., Rorsman, P., & Eliasson, L. (2009) · Diabetologia · doi:10.1007/s00125-009-1635-x · Cited by 22
Poto, C. D., Iadarola, P., Bardoni, A., Passadore, I., Giorgetti, S., Cereda, C., Carrı̀, M. T., Ceroni, M., & Salvini, R. (2007) · Electrophoresis · doi:10.1002/elps.200700455 · Cited by 14
Uncoupling protein 2 negatively regulates glucose-induced glucagon-like peptide 1 secretion
Zhang, H., Li, J., Liang, X., Luo, Y., Zen, K., & Zhang, C. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0114 · Cited by 14
Tancredi, M., Marselli, L., Lencioni, C., Masini, M., Bugliani, M., Suleiman, M., Masiello, P., Boggi, U., Filipponi, F., Dotta, F., et al. (2011) · Islets · doi:10.4161/isl.3.5.15940 · Cited by 11
Self-citationJensen, P. B., Larsen, P. J., Karlsen, C., Jensen, H. I., Holst, J. J., & Madsen, O. D. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01439.x · Cited by 4
Cited by
Pharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500
Incretin hormones: Their role in health and disease
Nauck, M. A., & Meier, J. J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13129 · Cited by 950
Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men
Rorsman, P., & Ashcroft, F. M. (2018) · Physiological Reviews · doi:10.1152/physrev.00008.2017 · Cited by 793
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498
Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
Deacon, C. F. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00080 · Cited by 428
Metadata
- Authors
- Marchetti, P., Lupi, R., Bugliani, M., Kirkpatrick, C. L., Sebastiani, G., Grieco, F. A., Del Guerra, S., D’Aleo, V., Piro, S., Marselli, L., Boggi, U., Filipponi, F., Tinti, L., Salvini, L., Wollheim, C. B., Purrello, F., & Dotta, F.
- Venue
- Diabetologia
- Published
- 2012-09-11
- Volume
- 55
- Issue
- 12
- Pages
- 3262-3272
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2021979767
- Cited by
- 259
- References
- 49
- FWCI
- 19.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.